Results 191 to 200 of about 35,812 (218)

Neuroendocrine differentiation and hormone-refractory prostate cancer

The Prostate, 1996
There is an intriguing link between differentiation of neuroendocrine cells and tumor progression in prostate cancer. Neuroendocrine differentiation appears to be associated with the androgen-independent state, for which there is currently no successful therapy.
openaire   +2 more sources

Neuroendocrine differentiation in prostate cancer

Urology, 2006
Shariff, Amir H, Ather, M Hammad
openaire   +2 more sources

The spectrum of neuroendocrine differentiation in prostate cancer

Prostate Cancer and Prostatic Diseases, 2021
Siyuan Cheng, Xiuping Yu
openaire   +2 more sources

ASCL1 Drives the Development of Neuroendocrine Prostate Cancer

Cancer Research
Therapeutic resistance to androgen receptor (AR)–targeting agents remains a significant clinical problem during the treatment of prostate cancer, with the incidence rate of resistant disease increasing as more men are treated with next-generation AR-targeted therapies.
Caden N. McQuillen, Nicholas J. Brady
openaire   +2 more sources

Genetic testing in prostate cancer management: Considerations informing primary care

Ca-A Cancer Journal for Clinicians, 2022
Todd M Morgan, Mary-Ellen Taplin, Veda N Giri   +2 more
exaly  

Neuroendocrine Prostate Cancer

2012
Himisha Beltran, Juan Miguel Mosquera, Mark A. Rubin   +2 more
openaire   +1 more source

Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer

Ca-A Cancer Journal for Clinicians, 2016
Peter A Pinto, Bradford J. Wood, Sandeep Sankineni   +2 more
exaly  

Neuroendocrine Prostate Cancer

2017
Shaham Beg, Juan Miguel Mosquera
openaire   +1 more source

Expectant management for men with early stage prostate cancer

Ca-A Cancer Journal for Clinicians, 2015
Christopher P Filson
exaly  

Progress and controversies: Radiation therapy for prostate cancer

Ca-A Cancer Journal for Clinicians, 2014
Neil E Martin
exaly